Lyell Immunopharma Announces ~$80M Private Placement Of 7.4M Shares At $10.77/Share
The investors include ARCH Venture Partners, Adage Capital Management LP, Caligan Partners LP, RTW Investments, a leading mutual fund and other new and existing institutional investors.The financing is expected to
Lyell Immunopharma raised about 80 million dollars from big investors. This money helps the company keep growing its science work.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.